121/316US=14 / Dermatologia
Naldi L, Sassi F. Evaluation of patient education. In: Ulrich ESC, Euvrard S, Proby C, Bavinck JNB, Geissler EK. Skin cancer after organ transplantation. New York: Springer, 2009. p. 417-23. (Cancer Treatment and Reseach) ISBN 978-0-387-78573-8.

EDUCACAO DO PACIENTE; EDUCACAO PARA A SAUDE; MUDANCAS COMPORTAMENTAIS; RECEPTORES DE ORGAOS TRANSPLANTADOS


122/316US=14 / Dermatologia
Nicholson S. Management of metastatic skin cancers in organ transplant recipients. In: Ulrich ESC, Euvrard S, Proby C, Bavinck JNB, Geissler EK. Skin cancer after organ transplantation. New York: Springer, 2009. p. 467-81. (Cancer Treatment and Reseach) ISBN 978-0-387-78573-8.

CANCER DE PELE METASTATICO; RECEPTORES DE ORGAOS TRANSPLANTADOS; CANCER DE PELE METASTATICO. TRATAMENTO


123/316US=16 / Estatística
Serraino D, Piselli P. Cancer cohort consortium approach: cancer epidemiology in immunosuppressed groups. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 409-19. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1.

CANCER. FATORES DE RISCO; HIV; IMUNOSSUPRESSAO; RECEPTORES DE TRANSPLANTES; SUL DA EUROPA


124/316US=11 / Fisiologia
Clare C. The endocrine system and associated disorders. In: Nair M, Peate I. Fundamentals of applied pathophysiology: an essential guide for nursing students. Oxford: John Wiley & Sons, 2009. p. 318-48. ISBN 978-0-470-51795-6.

SISTEMA ENDOCRINO. DISTURBIOS; HORMONIOS; HOMEOSTASE; RECEPTORES; AUMENTO DA REGULACAO; BAIXA DA REGULACAO; FEEDBACK NEGATIVO; HIPOTALAMO; EFEITO CALORIGENICO; GLUCAGON; CORTICOSTEROIDES; HIPOSECRECAO; HIPERSECRECAO; GLANDULAS ENDOCRINAS. FISIOLOGIA; TIREOIDE; GLANDULAS PARATIREOIDES; GLANDULAS ADRENAIS; PANCREAS; GLANDULA PITUITARIA; HIPOPITUITARISMO; HIPERTIREOIDISMO; HIPOTIREOIDISMO; DIABETES TIPO 1; DIABETES TIPO 2


125/316US=9 / Quimioterapia
Shin S, Kensler TW. Dietary factors regulate metabolism of carcinogens throughtranscriptional signaling pathways. In: Knasmüller S, DeMarini DM, Johnson I, Gerhäuser C. Chemoprevention of cancer and DNA damage by dietary factors. Weinheim: Wiley-VCH, 2009. p. 109-20. ISBN 978-3-527-32058-5.

FATORES DIETETICOS; METABOLISMO DE CARCINOGENOS; VIAS DE SINALIZACAO TRANSCRICIONAIS; NRF2; FATOR NUCLEAR ERITROIDE 2; NRF2-KEAP1; FOSFORILACAO; RECEPTOR DE HIDROCARBONETO AROMATICO; RECEPTORES NUCLEARES


126/316US=22 / Urologia
Lam JS, Figlin RA, Belldegrum AS,. VEGF: and PDGF receptors: biologic relevance and clinical approaches to inhibition. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 119-49. ISBN 978-1-58829-737-2.

DERIVADO DE PLAQUETAS FACTOR DE CRESCIMENTO; RECEPTORES; TRANSDUCAO DE SINAL; TIROSINA-QUINASE; FACTOR DE CRESCIMENTO ENDOTELIAL VASCULAR


127/316US=24 / Patologia
Rosen PP. Intraductal carcinoma. In: ___. Rosen's breast pathology. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 285-357. ISBN 978-0-7817-7137-5.

MAMA; CARCINOMA INTRADUCTAL; CARCINOMA INTRADUCTAL PALPAVEL; ANGIOGENESE; RECEPTORES HORMONAIS; ONCOGENE; TAXA DE PLOIDIA; PROLIFERACAO CELULAR; CITOGENETICA; GENETICA MOLECULAR; BIOPSIA POR AGULHA; LINFONODO SENTINELA


128/316US=27-A / Clin/Médica
Gill GN, Clemmons DR. Princípios de endocrinologia. In: Goldman L, Ausiello D, editors. Cecil medicina. 23ªed. Rio de Janeiro: Elsevier, 2009. p. 1903-14. ISBN 85-3522660-7.

HORMONIOS; RECEPTORES; PROTEINAS TIROSINA QUINASES; FUNCOES ENDOCRINAS; ANOMALIAS ENDOCRINAS


129/316US=8 / Laboratório
Neel BG, Carpenter CL. Regulation of cellular response. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 49-60. ISBN 978-0-443-06715-0.

REGULACAO DA RESPOSTA CELULAR; HEMATOPOIESE; CELULAS HEMATOPOIETICAS; RECEPTORES; PROTEINAS QUINASES; PROTEINAS FOSFATASES; PROTEINAS DE LIGACAO DO GUANOSINA-TRIFOSFATO; FOSFATIDILINOSITOL; FOSFOLIPASES; DOMINIOS DE LIGACAO PROTEINA-PROTEINA; DOMINIOS DE LIGACAO PROTEINA-LIPIDIO


130/316US=8 / Laboratório
Benson DM Jr, Caligiuri MA. Natural killer cell immunity. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 129-34. ISBN 978-0-443-06715-0.

IMUNIDADE; CELULAS NK; DESENVOLVIMENTO DAS CELULAS NK; RECEPTORES DAS CELULAS NK; DOENCAS; POTENCIAL TERAPEUTICO DAS CELULAS NK


131/316US=8 / Laboratório
Shaheen M, Broxmeyer HE. The humoral regulation of hematopoiesis. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 253-75. ISBN 978-0-443-06715-0.

HEMATOPOIESE; REGULAMENTO HUMORAL; CITOCINAS; FATORES SOLUVEIS; PROGENITORAS HEMATOPOIETICAS; CELULAS ESTAMINAIS; RECEPTORES DE CITOCINAS; RECEPTORES DE QUIMIOCINA; ATIVIDADE HEMATOPOIETICAS; REGULADORES DE CELULAS-TRONCO; FATORES DE CRESCIMENTO


132/316US=33 / Dor/Paliativo
Davis MP, Pasternak GW. Opioid receptors and opioid pharmacodynamics. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 1-27. ISBN 978-0-19-923664-0.

RECEPTORES OPIOIDES; FARMACODINAMICA OPIOIDE; OPIACEOS; PEPTIDEOS OPIOIDES; FARMACOGENOMICA ANTAGONISTAS; ANALGESIA OPIOIDE; TOLERANCIA ANALGESICO; DEPENDENCIA DOS OPIACEOS; DIMERIZACAO DE RECEPTORES DE OPIOIDES


133/316US=8 / Laboratório
Petersdorf EW, Anasetti C. Unrelated donor hematopoietic cell transplantation. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 1619-31. ISBN 978-0-443-06715-0.

TRANSPLANTE DE CELULAS HEMATOPOIETICAS; SELECAO DE DOADORES; TIPAGEM HLA; AVALIACAO DO DESCASAMENTO; AVALIACAO DOS HAPLOTIPOS HLA; TRANSPLANTE ALOGENICO DE CELULAS PROGENITORAS HEMATOPOETICAS (HCT); HLA-C; HAPLOTIPOS MHC; GENES DO MHC; RECEPTORES KIR; LEUCEMIA AGUDA; LEUCEMIA MIELOIDE AGUDA; LEUCEMIA LINFOBLASTICA AGUDA; SINDROME MIELOPROLIFERATIVA; SINDROME MIELODISPLASICA; LEUCEMIA MIELOIDE CRONICA


134/316US=50 / Câncer
Muller A, Homey B, Ferris RL. Head and neck cancer: an example for role of chemokine receptors in tumor progression and metastasis. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 243-54. ISBN 978-1-60327-086-1.

CANCER DA CABECA E PESCOCO; RECEPTORES DE QUIMIOCINA EM PROGRESSAO TUMORAL; QUIMIOCINA; RECEPTOR DE QUIMIOCINA; CANCER DE CABECA E PESCOCO; INVASAO E METASTASE; CXCR4; CCR7


135/316US=50 / Câncer
Heckman CA, Holopainen T, Alitalo K. Molecular targeting of lymphangiogenesis and tumor metastasis. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 283-95. ISBN 978-1-60327-086-1.

LINFANGIOGENESE; METASTASE LINFATICA; MOLECULAS LINFANGIOGENICAS; INIBIDORES DA QUINASE DE TIROSINA; RECEPTORES SOLUVEIS; ANTICORPOS BLOQUEADORES


136/316US=50 / Câncer
Ma WW, Jimeno A, Choti MA. Advances in the treatment of colorectal cancertargeting receptors of disease. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 523-32. ISBN 978-1-60327-086-1.

TRATAMENTO DO CANCER COLORECTAL; RECEPTORES DE SEGMENTACAO DE DOENCA; CANCER COLORRETAL; BEVACIZUMAB; CETUXIMAB; PANITUMUMAB; KRAS


137/316US=64 / Clin/Médica
Rizzo LV. Infecção por HIV e AIDS: imunopatogenia. In: Focaccia R, editor. Veronesi tratado de infectologia. 4 ed. rev atual. São Paulo: Atheneu, 2009. p. 156-61. ISBN 85-3880101-6.

DOENCA INFECCIOSA; AIDS; HIV; SINTESE DE CITOCINAS; APOPTOSE; REGULACAO DOS GENES; RECEPTORES DE QUIMIOCINA


138/316US=96 / Biol/Mol
Penning TM, Byrns MC. Steroid hormone transforming aldo-keto reductases and cancer. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 33-42. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ALDO-CETO FAMILIA REDUTASE; NSAIDS; DESIDROGENASE HIDROXIESTEROIDE; NAO ESTEROIDES ANTI-INFLAMATORIOS; PROSTAGLANDINA F; RECEPTORES NUCLEARES


139/316US=96 / Biol/Mol
Berasain C, Castillo J, Perugorria MJ, Latasa MU, Pietro J, Avila MA. Inflammation and liver cancer. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 206-21. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

CARCINOMA HEPATOCELULAR; INFLAMACAO; FATOR NUCLEAR-&*1181;B; NF-&*1181;B; STAT3; IL-6; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; AMPHIREGULIN; TOLL-LIKE RECEPTOR; TLR; RECONHECIMENTO DE RECEPTORES PADRAO; PRRS


140/316US=96 / Biol/Mol
Cusimano A, Foderà D, Lampiasi N, Azzolina A, Notarbartolo M, Giannitrapani L, D'Alessandro N, Montalto G, Cervello M. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 300-8. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

HCC; EP RECEPTORES; COX-1; COX-2; NSAIDS; HEPATOCELLULAR CARCINOMA


Primeira | Anterior | Próxima | Última